Javascript must be enabled to continue!
Multipotent Mesenchymal Stem Cells Acquire a Lymphendothelial Phenotype and Enhance Lymphatic Regeneration In Vivo
View through CrossRef
Background—
The importance and therapeutic value of stem cells in lymphangiogenesis are poorly understood. We evaluated the potential of human and murine mesenchymal stem cells (MSCs) to acquire a lymphatic phenotype in vitro and to enhance lymphatic regeneration in vivo.
Methods and Results—
We assessed the lymphendothelial differentiation of human and murine MSCs after induction with supernatant derived from human dermal microvascular endothelial cells, isolated lymphatic endothelial cells, and purified vascular endothelial growth factor (VEGF)-C in vitro. We used human or murine progenitor MSC lines and then characterized the lymphatic phenotype by morphology, migratory capacity, and the expression of lymphatic markers such as Prox-1, podoplanin, Lyve-1, VEGF receptor-2, and VEGF receptor-3. Using a murine lymphatic edema model, we assessed the potential of these cells to form a functional lymphatic vasculature in vivo after injection of syngeneic MSCs. Incubation with supernatant from lymphatic endothelial cells induced an endothelium-like morphology and the expression of lymphendothelial markers in both human and murine MSCs in vitro. MSCs showed migratory activity along a VEGF-C gradient, which was enhanced by VEGF-C conditioning. In vivo, the local application of MSCs resulted in a significant decrease in edema formation (−20.1%;
P
<0.01 versus untreated tails) after 3 weekly cell injections and restored the drainage of intradermally injected methylene blue after 7 weekly injections.
Conclusions—
MSCs were capable of expressing a lymphatic phenotype when exposed to lymph-inductive media and purified VEGF-C. Migratory activity toward VEGF-C in vitro suggests homing capability in vivo. Restoration of lymphatic drainage after injection of MSCs in a lymphedema model indicates that MSCs play a role in lymphatic regeneration. The potential clinical application of MSC in wound healing and reduction of lymphatic edema warrants further research.
Ovid Technologies (Wolters Kluwer Health)
Title: Multipotent Mesenchymal Stem Cells Acquire a Lymphendothelial Phenotype and Enhance Lymphatic Regeneration In Vivo
Description:
Background—
The importance and therapeutic value of stem cells in lymphangiogenesis are poorly understood.
We evaluated the potential of human and murine mesenchymal stem cells (MSCs) to acquire a lymphatic phenotype in vitro and to enhance lymphatic regeneration in vivo.
Methods and Results—
We assessed the lymphendothelial differentiation of human and murine MSCs after induction with supernatant derived from human dermal microvascular endothelial cells, isolated lymphatic endothelial cells, and purified vascular endothelial growth factor (VEGF)-C in vitro.
We used human or murine progenitor MSC lines and then characterized the lymphatic phenotype by morphology, migratory capacity, and the expression of lymphatic markers such as Prox-1, podoplanin, Lyve-1, VEGF receptor-2, and VEGF receptor-3.
Using a murine lymphatic edema model, we assessed the potential of these cells to form a functional lymphatic vasculature in vivo after injection of syngeneic MSCs.
Incubation with supernatant from lymphatic endothelial cells induced an endothelium-like morphology and the expression of lymphendothelial markers in both human and murine MSCs in vitro.
MSCs showed migratory activity along a VEGF-C gradient, which was enhanced by VEGF-C conditioning.
In vivo, the local application of MSCs resulted in a significant decrease in edema formation (−20.
1%;
P
<0.
01 versus untreated tails) after 3 weekly cell injections and restored the drainage of intradermally injected methylene blue after 7 weekly injections.
Conclusions—
MSCs were capable of expressing a lymphatic phenotype when exposed to lymph-inductive media and purified VEGF-C.
Migratory activity toward VEGF-C in vitro suggests homing capability in vivo.
Restoration of lymphatic drainage after injection of MSCs in a lymphedema model indicates that MSCs play a role in lymphatic regeneration.
The potential clinical application of MSC in wound healing and reduction of lymphatic edema warrants further research.
Related Results
Unusual Presentation of Mixed Lymphatic Malformation: A Case Report with Literature Review
Unusual Presentation of Mixed Lymphatic Malformation: A Case Report with Literature Review
Abstract
Introduction
There is a scarcity of reports on mixed lymphatic malformation. This case highlights a child with an extensive mixed lymphatic malformation, disfiguring multi...
Stem cells
Stem cells
What is a stem cell? The term is a combination of ‘cell’ and ‘stem’. A cell is a major category of living thing, while a stem is a site of growth and support for something else. In...
Differential marker expression by cultures rich in mesenchymal stem cells
Differential marker expression by cultures rich in mesenchymal stem cells
AbstractBackgroundMesenchymal stem cells have properties that make them amenable to therapeutic use. However, the acceptance of mesenchymal stem cells in clinical practice requires...
The Study on Lymphatic Cysts Caused by Lymphadenectomy
The Study on Lymphatic Cysts Caused by Lymphadenectomy
<i>Background</i>: Traumatic lymphatic cyst, also known as cystic lymphangioma, is a multidisciplinary disease, with congenital lymphatic cysts being mo...
Abstract 1488: Metastatic analysis of clonal epithelial and mesenchymal-like murine mammary tumor cells.
Abstract 1488: Metastatic analysis of clonal epithelial and mesenchymal-like murine mammary tumor cells.
Abstract
Tumor metastasis is the most common cause of cancer mortality, and yet it is among the most poorly understood processes in tumor progression. While carcinom...
Myogenic-induced mesenchymal stem cells are capable of modulating the immune response by regulatory T cells
Myogenic-induced mesenchymal stem cells are capable of modulating the immune response by regulatory T cells
Cell therapy for patients who have intractable muscle disorders may require highly regenerative cells from young, healthy allogeneic donors. Mesenchymal stem cells are currently un...
Regeneration inHydra
Regeneration inHydra
AbstractHydrafreshwater polyps have a remarkable ability to regenerate after bisection or even after dissociation, and thus offer a unique model system to investigate the cellular ...
Obesity‐Induced Lymphatic Valve Dysfunction
Obesity‐Induced Lymphatic Valve Dysfunction
A two‐way connection between obesity and lymphatic dysfunction has now been established. Clinical studies have demonstrated that obesity significantly increases the risk for develo...

